264 related articles for article (PubMed ID: 2656141)
1. Lipoproteins and apolipoproteins in young nonobese Arab women with NIDDM treated with insulin.
Al-Muhtaseb N; Al-Yusuf AR; Abdella N; Fenech F
Diabetes Care; 1989 May; 12(5):325-31. PubMed ID: 2656141
[TBL] [Abstract][Full Text] [Related]
2. Plasma lipoproteins and apolipoproteins in insulin-dependent and young non-insulin-dependent Arab women.
al-Muhtaseb N; al-Yuosuf AR; Bajaj JS
Acta Diabetol Lat; 1991; 28(1):61-9. PubMed ID: 1862693
[TBL] [Abstract][Full Text] [Related]
3. Lipoprotein lipids and apolipoproteins (AI, AII, B, CII, CIII) in type 1 and type 2 diabetes mellitus in young Kuwaiti women.
al-Muhtaseb N; al-Yusef AR; Bajaj JS
Diabet Med; 1991 Oct; 8(8):732-7. PubMed ID: 1838064
[TBL] [Abstract][Full Text] [Related]
4. Lipoprotein compositional abnormalities in type 1 (insulin-dependent) diabetic patients.
Manzato E; Zambon A; Zambon S; Nosadini R; Doria A; Marin R; Crepaldi G
Acta Diabetol; 1993; 30(1):11-6. PubMed ID: 8329725
[TBL] [Abstract][Full Text] [Related]
5. Lipoprotein subfraction composition in non-obese newly diagnosed non-insulin dependent diabetes after treatment with diet and glibenclamide.
Billingham MS; Milles JJ; Bailey CJ; Hall RA
Diabetes Res; 1989 May; 11(1):13-20. PubMed ID: 2515931
[TBL] [Abstract][Full Text] [Related]
6. Abnormal lipoprotein composition in normolipidemic diabetic patients.
Iwai M; Yoshino G; Matsushita M; Morita M; Matsuba K; Kazumi T; Baba S
Diabetes Care; 1990 Jul; 13(7):792-6. PubMed ID: 2201502
[TBL] [Abstract][Full Text] [Related]
7. Lipoprotein abnormalities in well-treated type II diabetic patients.
Manzato E; Zambon A; Lapolla A; Zambon S; Braghetto L; Crepaldi G; Fedele D
Diabetes Care; 1993 Feb; 16(2):469-75. PubMed ID: 8432219
[TBL] [Abstract][Full Text] [Related]
8. Persistent abnormalities in lipoprotein composition in noninsulin-dependent diabetes after intensive insulin therapy.
Bagdade JD; Buchanan WE; Kuusi T; Taskinen MR
Arteriosclerosis; 1990; 10(2):232-9. PubMed ID: 2180397
[TBL] [Abstract][Full Text] [Related]
9. Doxazosin reduces prevalence of small dense low density lipoprotein and remnant-like particle cholesterol levels in nondiabetic and diabetic hypertensive patients.
Hirano T; Yoshino G; Kashiwazaki K; Adachi M
Am J Hypertens; 2001 Sep; 14(9 Pt 1):908-13. PubMed ID: 11587157
[TBL] [Abstract][Full Text] [Related]
10. Complementary insulin therapy improves blood glucose and serum lipid parameters in type 2 (non-insulin-dependent) diabetic patients. II. Effects on serum lipids, lipoproteins and apoproteins.
Vaverková H; Chlup R; Ficker L; Novotny D; Bartek J
Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 2():74-7. PubMed ID: 9288551
[TBL] [Abstract][Full Text] [Related]
11. Lipoprotein compositional abnormalities and insulin resistance in type II diabetic patients with mild hyperlipidemia.
Stewart MW; Laker MF; Dyer RG; Game F; Mitcheson J; Winocour PH; Alberti KG
Arterioscler Thromb; 1993 Jul; 13(7):1046-52. PubMed ID: 8318506
[TBL] [Abstract][Full Text] [Related]
12. Serum lipids and lipoprotein(a) concentrations in Chinese NIDDM patients. Relation to metabolic control.
Chang CJ; Kao JT; Wu TJ; Lu FH; Tai TY
Diabetes Care; 1995 Aug; 18(8):1191-4. PubMed ID: 7587858
[TBL] [Abstract][Full Text] [Related]
13. Adverse effects of obesity on lipid and lipoprotein levels in insulin-dependent and non-insulin-dependent diabetes.
Laakso M; Pyörälä K
Metabolism; 1990 Feb; 39(2):117-22. PubMed ID: 2299984
[TBL] [Abstract][Full Text] [Related]
14. Short-term oestrogen replacement therapy improves insulin resistance, lipids and fibrinolysis in postmenopausal women with NIDDM.
Brussaard HE; Gevers Leuven JA; Frölich M; Kluft C; Krans HM
Diabetologia; 1997 Jul; 40(7):843-9. PubMed ID: 9243107
[TBL] [Abstract][Full Text] [Related]
15. Increased hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in NIDDM.
Cummings MH; Watts GF; Umpleby AM; Hennessy TR; Naoumova R; Slavin BM; Thompson GR; Sönksen PH
Diabetologia; 1995 Aug; 38(8):959-67. PubMed ID: 7589883
[TBL] [Abstract][Full Text] [Related]
16. Effect of insulin-dependent diabetes on plasma lipoproteins in diabetic pregnancy.
Knopp RH; Van Allen MI; McNeely M; Walden CE; Plovie B; Shiota K; Brown Z
J Reprod Med; 1993 Sep; 38(9):703-10. PubMed ID: 8254593
[TBL] [Abstract][Full Text] [Related]
17. Effect of fish oil concentrate on lipoprotein composition in NIDDM.
Schectman G; Kaul S; Kissebah AH
Diabetes; 1988 Nov; 37(11):1567-73. PubMed ID: 3181646
[TBL] [Abstract][Full Text] [Related]
18. Lipid and lipoprotein patterns in type 2 non-obese diabetic patients. Do Lp(a) levels decrease with improved glycemic control in these patients?
Alagözlü H; Gültekin F; Candan F
Nutr Metab Cardiovasc Dis; 2000 Aug; 10(4):204-8. PubMed ID: 11079258
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein A-IV levels and phenotype distribution in NIDDM.
Vergès BL; Vaillant G; Goux A; Lagrost L; Brun JM; Gambert P
Diabetes Care; 1994 Aug; 17(8):810-7. PubMed ID: 7956623
[TBL] [Abstract][Full Text] [Related]
20. Quantitative and qualitative derangement of apolipoprotein B-containing lipoproteins as a risk factor for diabetic macroangiopathy in nonobese NIDDM subjects.
Harano Y; Kageyama A; Nakao Y; Hara Y; Suzuki M; Sato A; Ikebuchi M; Shinozaki K; Tsushima M
Diabetes; 1996 Jul; 45 Suppl 3():S31-4. PubMed ID: 8674886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
